- Home
- LNKB vs OSUR Comparison
LNKB vs OSUR Comparison
Compare LNKB & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNKB
- OSUR
- Stock Information
- Founded
- LNKB 2018
- OSUR 2000
- Country
- LNKB United States
- OSUR United States
- Employees
- LNKB N/A
- OSUR N/A
- Industry
- LNKB
- OSUR Medical/Dental Instruments
- Sector
- LNKB
- OSUR Health Care
- Exchange
- LNKB Nasdaq
- OSUR Nasdaq
- Market Cap
- LNKB 256.4M
- OSUR 233.4M
- IPO Year
- LNKB N/A
- OSUR 1986
- Fundamental
- Price
- LNKB $7.23
- OSUR $2.77
- Analyst Decision
- LNKB Strong Buy
- OSUR Hold
- Analyst Count
- LNKB 1
- OSUR 1
- Target Price
- LNKB $9.00
- OSUR $3.00
- AVG Volume (30 Days)
- LNKB 37.5K
- OSUR 553.7K
- Earning Date
- LNKB 07-28-2025
- OSUR 08-05-2025
- Dividend Yield
- LNKB 4.17%
- OSUR N/A
- EPS Growth
- LNKB N/A
- OSUR N/A
- EPS
- LNKB 1.01
- OSUR N/A
- Revenue
- LNKB $121,982,000.00
- OSUR $138,533,000.00
- Revenue This Year
- LNKB $21.03
- OSUR N/A
- Revenue Next Year
- LNKB N/A
- OSUR $6.80
- P/E Ratio
- LNKB $7.13
- OSUR N/A
- Revenue Growth
- LNKB 79.01
- OSUR N/A
- 52 Week Low
- LNKB $6.00
- OSUR $2.36
- 52 Week High
- LNKB $7.98
- OSUR $4.61
- Technical
- Relative Strength Index (RSI)
- LNKB 57.94
- OSUR 36.84
- Support Level
- LNKB $6.57
- OSUR $2.75
- Resistance Level
- LNKB $7.53
- OSUR $2.96
- Average True Range (ATR)
- LNKB 0.24
- OSUR 0.15
- MACD
- LNKB 0.04
- OSUR -0.05
- Stochastic Oscillator
- LNKB 83.85
- OSUR 14.29
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.